Identifying Oxacillinase-48 Carbapenemase Inhibitors Using DNA-Encoded Chemical Libraries
- 17 March 2020
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Infectious Diseases
- Vol. 6 (5) , 1214-1227
Abstract
Bacterial resistance to β-lactam antibiotics is largely mediated by β-lactamases, which catalyze the hydrolysis of these drugs and continue to emerge in response to antibiotic use. β-Lactamases that hydrolyze the last resort carbapenem class of β-lactam antibiotics (carbapenemases) are a growing global health threat. Inhibitors have been developed to prevent β-lactamase-mediated hydrolysis and restore the efficacy of these antibiotics. However, there are few inhibitors available for problematic carbapenemases such as oxacillinase-48 (OXA-48). A DNA-encoded chemical library approach was used to rapidly screen for compounds that bind and potentially inhibit OXA-48. Using this approach, a hit compound, CDD-97, was identified with submicromolar potency (Ki = 0.53 ± 0.08 μM) against OXA-48. X-ray crystallography showed that CDD-97 binds noncovalently in the active site of OXA-48. Synthesis and testing of derivatives of CDD-97 revealed structure–activity relationships and informed the design of a compound with a 2-fold increase in potency. CDD-97, however, synergizes poorly with β-lactam antibiotics to inhibit the growth of bacteria expressing OXA-48 due to poor accumulation into E. coli. Despite the low in vivo activity, CDD-97 provides new insights into OXA-48 inhibition and demonstrates the potential of using DNA-encoded chemistry technology to rapidly identify β-lactamase binders and to study β-lactamase inhibition, leading to clinically useful inhibitors.Keywords
Funding Information
- Welch Foundation (H-Q-0042)
- National Institute of Allergy and Infectious Diseases (AI143832, AI32956)
- Cancer Prevention and Research Institute of Texas (RP160805)
- Office of Science (DE-AC02-05CH11231)
- National Institute of General Medical Sciences (GM120011, GM124169-01)
This publication has 89 references indexed in Scilit:
- Avibactam is a covalent, reversible, non–β-lactam β-lactamase inhibitorProceedings of the National Academy of Sciences, 2012
- Antibiotic resistance is ancient: implications for drug discoveryTrends in Microbiology, 2012
- Emergence and clonal dissemination of carbapenem-hydrolysing OXA-58-producing Acinetobacter baumannii isolates in BoliviaJournal of Medical Microbiology, 2012
- In Vitro Selection of a DNA-Templated Small-Molecule Library Reveals a Class of Macrocyclic Kinase InhibitorsJournal of the American Chemical Society, 2010
- PHENIX: a comprehensive Python-based system for macromolecular structure solutionActa Crystallographica Section D Structural Biology, 2010
- MolProbity: all-atom structure validation for macromolecular crystallographyActa Crystallographica Section D Structural Biology, 2009
- Outer membrane permeability and antibiotic resistanceBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2009
- Phasercrystallographic softwareJournal of Applied Crystallography, 2007
- Crystal structure of the carbapenemase OXA-24 reveals insights into the mechanism of carbapenem hydrolysisProceedings of the National Academy of Sciences, 2007
- Coot: model-building tools for molecular graphicsActa Crystallographica Section D Structural Biology, 2004